NCT05552430

Brief Summary

The goal of this study is to pilot test a skills-based virtual reality (VR) for acute orthopedic injury. It will measure the feasibility, signals of improvement, exploratory pain mechanisms, and user experience of an established skills-based program (RelieveVRx) for acute orthopedic injury.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 23, 2022

Completed
24 days until next milestone

Study Start

First participant enrolled

October 17, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 12, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 12, 2023

Completed
11 months until next milestone

Results Posted

Study results publicly available

August 22, 2024

Completed
Last Updated

August 22, 2024

Status Verified

August 1, 2024

Enrollment Period

12 months

First QC Date

September 20, 2022

Results QC Date

May 13, 2024

Last Update Submit

August 20, 2024

Conditions

Keywords

paindisabilityinjuryorthopedicsrehabilitationmind-body

Outcome Measures

Primary Outcomes (4)

  • Credibility and Expectancy Questionnaire (CEQ)- Credibility Subscale

    Participants' perceived credibility, determined by the percentage of participants with scores (range = 3-27, higher scores mean better outcomes) over the scale's midpoint (≥70% good, ≥ 80% excellent).

    Pre-intervention (week 0) only

  • Credibility and Expectancy Questionnaire (CEQ)- Expectancy Subscale

    Participants' treatment expectancy, determined by the percentage of participants with scores (range = 3-27, higher scores mean better outcomes) over the scale's midpoint (≥70% good, ≥ 80% excellent).

    Pre-intervention (week 0) only

  • Client Satisfaction Questionnaire

    Participants' treatment satisfaction, determined by the percentage of participants with scores (range = 3-12) over the scale's midpoint (≥70% good, ≥ 80% excellent).

    Post-intervention (week 8) only

  • System Usability Scale

    Assess global user experience of the VR device, with higher percentile rankings (range = 0-100) indicating greater usability. Usability was determined by the number of participants with System Usability Scale scores 68 and above (≥70% good, ≥ 80% excellent).

    Post-intervention (week 8) only

Secondary Outcomes (6)

  • Patient's Global Impression of Change

    Post-intervention (week 8) only

  • Motion Sickness and Nausea

    Post-intervention (week 8) only

  • Feasibility of Enrollment

    Throughout the study completion, approximately 1 year

  • Acceptability of Treatment

    Pre-intervention (week 0), Post-intervention (week 8)

  • Adherence to Pain Surveys

    Pre-intervention (week 0), Post-intervention (week 8)

  • +1 more secondary outcomes

Other Outcomes (17)

  • Non-narcotic Pain Medications

    Pre-intervention (week 0), Post-intervention (week 8)

  • Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance

    Pre-intervention (week 0), Post-intervention (week 8)

  • Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function

    Pre-intervention (week 0), Post-intervention (week 8)

  • +14 more other outcomes

Study Arms (1)

Skills-Based VR

EXPERIMENTAL

Participants will complete daily skills-based Virtual Reality (VR) sessions for 8 weeks (an average of 6 minutes per day) to determine the feasibility of at-home VR technology to aid the recovery of acute orthopedic musculoskeletal injuries. The VR device software is equipped with pain-specific treatment modules (e.g., Pain Education, Relaxation/Interoception, Mindful Escapes, and Pain Distraction Games) derived from evidence-based principles of cognitive behavioral therapy (CBT), mindfulness, and pain neuroscience education.

Device: RelieveVRx

Interventions

Participants will complete daily skills-based Virtual Reality (VR) sessions for 8 weeks (an average of 6 minutes per day) to determine the feasibility of at-home VR technology to aid the recovery of acute orthopedic musculoskeletal injuries. The VR device software is equipped with pain-specific treatment modules (e.g., Pain Education, Relaxation/Interoception, Mindful Escapes, and Pain Distraction Games) derived from evidence-based principles of cognitive behavioral therapy (CBT), mindfulness, and pain neuroscience education.

Skills-Based VR

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Outpatient adults in the Level 1 Trauma Center
  • Age 18 or older
  • Able to meaningfully participate meaningfully (English fluency and literacy) and stable living situation
  • Acute musculoskeletal injury (e.g., fracture, dislocation, rupture) 1-2 months earlier (acute phase).
  • Pain Catastrophizing Scale ≥20 or Pain Anxiety Symptom Scale-20 ≥40
  • Has access to internet (Wi-Fi or wireless)
  • Willing to participate and comply with the requirements of the study protocol, including virtual reality program and questionnaire completion No psychotropics or stable for \>6 weeks
  • Free of concurrent psychotropic medication for at least 2 weeks prior to initiation of treatment, OR stable on current psychotropic medication for a minimum of 6 weeks and willing to maintain a stable dose (i.e., no psychotropics or stable for \>6 weeks)
  • Cleared by orthopedic surgeon for study participation

You may not qualify if:

  • Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, or other neurological diseases that are contraindicated for VR
  • Medical condition predisposing to nausea or dizziness.
  • Hypersensitivity to flashing light or motion.
  • Vision or severe hearing impairment.
  • Injury to eyes, face, or neck that impedes comfortable use of virtual reality
  • Diagnosed with a medical illness expected to worsen in the next 3 months (e.g., malignancy)
  • Other serious injuries that occurred with the orthopedic injury or surgical complications (e.g., infection, need for repeat surgery)
  • Current or prior untreated mental illness, substance use disorder, or suicidal ideation
  • Self-reported pregnancy
  • Currently in litigation or under Workman's Comp
  • Practice of cognitive-behavioral therapy, yoga/meditation, or other mind body techniques once per week for 45 minutes or more within the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Wounds and InjuriesArm InjuriesAthletic InjuriesKnee InjuriesWrist InjuriesAnkle InjuriesFoot InjuriesHand InjuriesFinger InjuriesLeg InjuriesPain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Ryan Mace
Organization
Center for Health Outcomes and Interdisciplinary Research, Massachusetts General Hospital

Study Officials

  • Ryan A Mace, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Psychologist

Study Record Dates

First Submitted

September 20, 2022

First Posted

September 23, 2022

Study Start

October 17, 2022

Primary Completion

October 12, 2023

Study Completion

October 12, 2023

Last Updated

August 22, 2024

Results First Posted

August 22, 2024

Record last verified: 2024-08

Locations